Devices › Device types
FDA product code MJN · class 2 · Cardiovascular
Catheter, intravascular occluding, temporary: medical device reports filed with FDA
2,348 reports carry this product code, 1999–2026; 6 brands with a page.
- 2,348
- reports with this product code
- 0% of all MAUDE reports
- 206
- reports, 12 months to August 2026
- 205 in the 12 months before
- 75.4%
- classified as malfunction
- 62.3% across all reports
- 4.3%
- classified as death, as reported
- 0.9% across all reports
Product code MJN is FDA's classification for "Catheter, intravascular occluding, temporary" (cardiovascular panel), a class 2 device. 2,348 medical device reports carry this product code, 0% of the MAUDE database, from May 1999 to August 2026.
206 reports arrived in the 12 months to August 2026, close to the 205 of the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (75.4%), injury (19.5%) and death (4.3%). 6 brand names with a page on this site carry this code; the brands table is ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Brands with this product code
| Brand | Reports | Latest 12 months | Classified as death | Classified as malfunction |
|---|---|---|---|---|
| Pruitt F3 Carotid Shunt | 372 | 73 | 0.3% | 92.9% |
| Micrus Microcoil System | 87 | 0 | 5.4% | 46.1% |
| GORE Molding & Occlusion Balloon Catheter | 73 | 30 | 5.5% | 4.8% |
| Equalizer | 56 | 2 | 0% | 92.6% |
| Balloon | 2 | 48 | 0.3% | 71.5% |
| TufTex Over-the-Wire Embolectomy Catheter | 1 | 159 | 0% | 99.7% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Manufacturers named
| Manufacturer (as written on reports) | Reports | Share |
|---|---|---|
| Lemaitre Vascular | 555 | 23.6% |
| Stryker Neurovascular Cork | 379 | 16.1% |
| Microvention | 198 | 8.4% |
| Micro Therapeutics Ev3 | 183 | 7.8% |
| Ev3 Neurovascular | 157 | 6.7% |
| Micrus Endovascular | 122 | 5.2% |
| Spectranetics | 61 | 2.6% |
| The Spectranetics | 61 | 2.6% |
| W L Gore & Associates | 50 | 2.1% |
| Covidien Irvine | 47 | 2% |
| Edwards Lifesciences Pr | 27 | 1.1% |
| Aga Medical | 15 | 0.6% |
| Cook | 6 | 0.3% |
| Horizon Medical Products | 6 | 0.3% |
| Codman And Shurtleff | 4 | 0.2% |
Reports by month, five years
FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
Event type and report source
Event type
Who filed
Grey bar: all 26,136,888 MAUDE reports.
Device problems coded
| Device problem (FDA code) | Reports | Share |
|---|---|---|
| Material rupture | 367 | 15.6% |
| Deflation problem | 327 | 13.9% |
| Leak/splashthe device leaked | 255 | 10.9% |
| Inflation problem | 227 | 9.7% |
| Burst container or vessel | 134 | 5.7% |
| Fluid/blood leak | 125 | 5.3% |
| Breakthe device broke | 85 | 3.6% |
| Material puncture/hole | 68 | 2.9% |
| Difficult to removethe device was hard to remove | 59 | 2.5% |
| Failure to deflate | 55 | 2.3% |
| Patient device interaction problem | 43 | 1.8% |
| Entrapment of device | 32 | 1.4% |
| Material deformation | 31 | 1.3% |
| Balloon rupture | 29 | 1.2% |
| Detachment of device component | 29 | 1.2% |
| Replace | 29 | 1.2% |
| Failure to advance | 28 | 1.2% |
| Device operates differently than expectedthe device behaved unexpectedly | 27 | 1.1% |
| Stretched | 27 | 1.1% |
| Hole in material | 26 | 1.1% |
Questions about catheter, intravascular occluding, temporary reports
What is product code MJN?
FDA's classification code for "Catheter, intravascular occluding, temporary", class 2, reviewed by the cardiovascular panel. Every device report carries the product code of the device involved.
How many reports carry this code?
2,348 reports through August 2026, 206 of them in the latest 12 months.
Which brands appear most often?
Pruitt F3 Carotid Shunt (372), Micrus Microcoil System (87), GORE Molding & Occlusion Balloon Catheter (73), Equalizer (56) and Balloon (2). Widely used products collect more reports because more people use them.
Can the brands table be used to rank the devices?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." Brands differ in how many are in use, how long they have been sold and how reports are collected.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.